An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

There is a clinical need for new, more effective treatments for chronic and debilitating inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. Targeting drugs selectively to the inflamed intestine may improve therapeutic outcomes and minimize systemic toxicity. We repor...

Full description

Bibliographic Details
Main Authors: Ermann, J., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., Zhang, Sufeng, Succi, Marc David, Traverso, Carlo Giovanni, Langer, Robert S, Karp, Jeffrey Michael
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: American Association for the Advancement of Science (AAAS) 2017
Online Access:http://hdl.handle.net/1721.1/109405
https://orcid.org/0000-0002-9481-2258
https://orcid.org/0000-0002-4260-2785
https://orcid.org/0000-0003-4255-0492

Similar Items

Similar Items